Full text is available at the source.
A Review on the Antitumor Activity of Various Nitrogenous-based Heterocyclic Compounds as NSCLC Inhibitors
Antitumor Effects of Different Nitrogen-Based Ring Compounds Against Non-Small Cell Lung Cancer
AI simplified
Abstract
Lung cancer accounts for approximately 15% of all cancer cases worldwide.
- Non-Small Cell Lung Carcinomas (NSCLCs) represent about 80% of lung cancer cases.
- Patient compliance in lung cancer treatment has been declining due to drug resistance and adverse effects.
- Nitrogen-containing heterocyclic compounds are associated with a wide range of biological activities, particularly antitumor effects.
- The review highlights the significant potential of nitrogen heterocycles as multi-target-directed inhibitors for NSCLCs.
- There is a need for innovative structural agents to inhibit NSCLCs effectively.
AI simplified